Fluorine F18-EF5
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fluorine F18-EF5, covering 2012-09-26 to 2012-09-26. Get the full timeline:
Most recent: Clinical Trial Update: Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [Phase 1]